Cases & Deals

  • Home
  • Practices
  • Creadev and France 2i participate in €60 million Series C financing round of M2i Lifesciences

Share

Creadev and France 2i participate in €60 million Series C financing round of M2i Lifesciences

September 2019

Client(s) Creadev SAS and France 2i

Jones Day represented Creadev SAS and France 2i (Raise Impact) in connection with the €60 million (US$66 million) Series C round of financing of M2i Lifesciences, a world leader in the field of pheromones for crop protection, animal health, and human health, producing agricultural chemical products.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.